The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ.
Li X, Hernandez I, Koyuncu S, Kis B, Häggblad M, Lidemalm L, Abbas AA, Bendegúz S, Göblös A, Brautigam L, Lucas JJ, Carreras-Puigvert J, Hühn D, Pircs K, Vilchez D, Fernandez-Capetillo O.
Li X, et al. Among authors: lucas jj.
EBioMedicine. 2024 May 2;103:105124. doi: 10.1016/j.ebiom.2024.105124. Online ahead of print.
EBioMedicine. 2024.
PMID: 38701619
Free PMC article.